| dc.contributor.author | Chemtai Mungo, Cyrillus Ogollah, Jennifer Ambaka, Jackton Omoto, Craig Cohen | |
| dc.date.accessioned | 2022-05-17T13:20:29Z | |
| dc.date.available | 2022-05-17T13:20:29Z | |
| dc.date.issued | 2022 | |
| dc.identifier.uri | https://repository.maseno.ac.ke/handle/123456789/5268 | |
| dc.description | https://ascopubs.org/doi/pdf/10.1200/GO.22.40000 | en_US |
| dc.description.abstract | In 2019, the World Health Organization (WHO) endorsed thermal ablation (TA) for use within “screen-and-treat” cervical cancer prevention programs in low- and middle-income countries (LMICs), including among women living with HIV (WLWH). We evaluated TA efficacy for treatment of biopsy-confirmed cervical intraepithelial neoplasia grades 2 and 3 (CIN2/3) among WLWH in western Kenya (ClinicalTrials.gov NCT04191967). | en_US |
| dc.publisher | Wolters Kluwer Health | en_US |
| dc.title | Efficacy of Thermal Ablation for Treatment of High-Grade Cervical Dysplasia Among HIV-Positive Women: Preliminary Results From Western Kenya | en_US |
| dc.type | Article | en_US |
